idarubicin has been researched along with Leukemia, Lymphoblastic, Acute, T Cell in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, KL; Fu, S; He, Y; Hu, KM; Hu, YX; Huang, H; Liu, LZ; Wang, BS; Wang, YJ; Wu, KN; Zhang, LF; Zhao, YM | 1 |
| Chung, NG; Jang, W; Kim, M; Lee, JW | 1 |
| Devidas, M; Gaynon, PS; Hastings, C; Lu, X; Nachman, JB; Sather, HN; Seibel, NL | 1 |
| Carrión Campo, R; Martínez Rubio, M; Moya Moya, MA; Rico Sergado, L; Saldaña Garrido, JD | 1 |
| Brown, AW; McGregor, BA; Osswald, MB; Savona, MR | 1 |
| Cao, WJ; Huang, H; Wang, YJ; Wu, GQ; Wu, KN; Yu, XH; Zhao, YM | 1 |
1 review(s) available for idarubicin and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
The use of higher dose clofarabine in adults with relapsed acute lymphoblastic leukemia.
Topics: Adenine Nucleotides; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Arabinonucleosides; Clinical Trials as Topic; Clofarabine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Drug Evaluation; Etoposide; Fatal Outcome; Filgrastim; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Male; Mitoxantrone; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recombinant Proteins; Recurrence; Remission Induction; Reoperation; Salvage Therapy; Vidarabine; Vincristine; Young Adult | 2009 |
1 trial(s) available for idarubicin and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Increased post-induction intensification improves outcome in children and adolescents with a markedly elevated white blood cell count (≥200 × 10(9) /l) with T cell acute lymphoblastic leukaemia but not B cell disease: a report from the Children's Oncology
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cranial Irradiation; Cyclophosphamide; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Doxorubicin; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Kaplan-Meier Estimate; Leukemia, B-Cell; Leukocyte Count; Leukocytosis; Male; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk; Treatment Outcome; Vincristine | 2015 |
4 other study(ies) available for idarubicin and Leukemia, Lymphoblastic, Acute, T Cell
| Article | Year |
|---|---|
Rapamycin interacts synergistically with idarubicin to induce T-leukemia cell apoptosis in vitro and in a mesenchymal stem cell simulated drug-resistant microenvironment via Akt/mammalian target of rapamycin and extracellular signal-related kinase signali
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Drug Synergism; Extracellular Signal-Regulated MAP Kinases; Humans; Idarubicin; Leukemia, T-Cell; Mesenchymal Stem Cells; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Tumor Microenvironment | 2014 |
Acute myeloid leukemia of mixed megakaryocytic and erythroid origin following chemotherapy for T-cell lymphoblastic lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cytarabine; Daunorubicin; Dexamethasone; Erythroid Cells; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Megakaryocytes; Mitoxantrone; Neoplasms, Second Primary; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Remission Induction; Vincristine | 2014 |
Leukaemic infiltration and cytomegalovirus retinitis in a patient with acute T-cell lymphoblastic leukaemia in complete remission.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cytarabine; Cytomegalovirus Retinitis; Female; Granulocyte Colony-Stimulating Factor; Humans; Idarubicin; Leukemic Infiltration; Papilledema; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Retina; Retinal Hemorrhage; Vidarabine | 2017 |
[Synergistic cytotoxic effects of rapamycin and idarubicin on human acute T-cell lymphoblastic leukemia Jurkat cells].
Topics: Apoptosis; Caspase 3; Cell Proliferation; Drug Synergism; Humans; Idarubicin; Jurkat Cells; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Sirolimus | 2011 |